A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction
Year: 1995
Type: article
Study design: Clinical Trial
Source: Annals of Surgical Oncology
DOI: 10.1007/bf02307026
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1998046384